LRCX

Lam Research has seen its share price whipsaw in recent months, with a sharp pullback following a long multiyear climb.

Jim Cramer called Lam Research the best in semiconductor capital equipment, yet he told investors to hold back on most of their planned purchase. The reason behind that caution reveals a tension worth understanding before you touch this stock.

According to the average brokerage recommendation (ABR), one should invest in Lam Research (LRCX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic.

Lam Research, Lockheed Martin and Equinor headline today's analyst reports, with AI-driven demand, defense contracts and energy growth shaping their investment outlooks.

For questions about this article or underlying research, email [email protected].

Zacks.com users have recently been watching Lam Research (LRCX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Lam Research (LRCX) kicked off its fiscal year with first quarter earnings that put fresh numbers around the story investors have been debating since summer. The report now serves as a key reference point for the latest move in the stock.

SK Hynix just forecast a memory shortage stretching years into the future, and the chip equipment makers who build the factories to fix it are surging. But supply bottlenecks and China exposure could determine whether this rally has real legs.

LRCX's foundry sales hit a record amid AI chip complexity, advanced packaging and China demand. Can 2027 WFE spending above $200B keep the momentum going?

For questions about this article or underlying research, email [email protected].